Post-Marketing Surveillance for Crohn's Disease Participants Treated With Stelara (Ustekinumab)

CompletedOBSERVATIONAL
Enrollment

685

Participants

Timeline

Start Date

April 8, 2019

Primary Completion Date

January 14, 2022

Study Completion Date

January 14, 2022

Conditions
Crohn Disease
Interventions
DRUG

Ustekinumab

Participants treated with ustekinumab under real world clinical practice will be observed in this study. No study drug will be administered as a part of this study.

Trial Locations (43)

13620

Seoul National University Bundang Hospital, Gyeonggi-do

The Catholic Univ. of Korea, DaeJeon St. Mary's Hospital, Seongnam

15355

Korea University Ansan Hospital, Gyeonggi-do

18450

Hallym University Dongtan Sacred Heart Hospital, Hwaseong-si

24253

Hallym University Chuncehon Medical Center, Chuncheon

24289

Kangwon National University Hospital, Chuncheon

31116

Dankook University Hospital, Cheonan-si

35015

Chungnam National University Hospital, Daejeon

41199

Daegu Fatima Hospital, Daegu

41404

Kyongpook national university Medical center, Daegu

Kyungpook National University Chilgok Hospital, Daegu

41944

Kyungpook National University Hospital, Daegu

42415

Yeungnam University Medical Center, Daegu

42601

Keimyung University Dongsan Hospital, Daegu

42644

Koo Hospital, Daegu

47392

Inje University Busan Paik Hospital, Busan

48108

Inje University Haeundae Paik Hospital, Busan

Kosin University Gospel Hospital, Busan

48265

Good Gangan Hospital, Busan

49241

Pusan National University Hospital, Busan

50612

Pusan National University Yangsan Hospital, Yangsan

51353

Samsung ChangWon Hospital, Changwon

51472

Changwon Kyunngsang University Hospital, Changwonsi

52727

GyeongSang National University Hospital, Jinju

120752

Yonsei University Severance Hospital - Dept.of Internal Medicine, Seoul

602 812

Dong-A University Hospital, Busan

Unknown

Soonchunhyang University Cheonan Hospital, Cheonan

Bucheon Soonchunhyang Hospital, Kyunggido

302-718

Konyang University Hospital, Daejeon

501-757

Chunnam National University Hospital, Gwangju

412-723

CHA Bundang Medical Center, CHA University, Seongnam

02447

Pusan National University Yangsan Hospital, Seoul

03080

Seoul National University Hospital, Seoul

03181

Kangbuk Samsung Hospital, Seoul

04401

Soonchunhyang University Seoul Hospital, Seoul

05505

Asan Medical Center, Seoul

06351

Hallym University Medical Center, Seoul

Samsung Medical Center, Seoul

06591

The Catholic University of Korea Seoul St Mary s Hospital, Seoul

06973

Chung-Ang University Hospital, Seoul

102-1703

KyungHee University Hospital, Seoul

135-720

Gangnam Severance Hospital, Seoul

158-710

Ewha Woman's University Seoul Hospital, Seoul

All Listed Sponsors
lead

Janssen Korea, Ltd., Korea

INDUSTRY

NCT03942120 - Post-Marketing Surveillance for Crohn's Disease Participants Treated With Stelara (Ustekinumab) | Biotech Hunter | Biotech Hunter